Health ❯ Diseases ❯ Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease Risk Factors Treatment Biomarkers Symptoms Research Research Findings Viral Infections Familial Alzheimer's Disease Molecular Mechanisms Diagnosis and Treatment Cytomegalovirus (HCMV) Tau Protein Herpes Simplex Virus Type 1 (HSV-1) Amyloid Beta Medically Acquired Alzheimer's Disease Human-to-Human Transmission Early-Onset Dementia Research and Diagnosis Amyloid Aggregation Glial Cells and Metabolism Glial Cells STING and Alzheimer's Amyotrophic Lateral Sclerosis Herpes Simplex Virus Type 1 Prevalence and Impact Amyloid Beta Fibrils APOE Gene Neuronal Degeneration Protein Analysis Genetics Synaptic Plasticity Lifestyle Factors Lithium Deficiency Fat Accumulation in Brain Cells Awareness and Support Cholesterol Transport Diagnosis Methods Amyloid Beta Protein APP Amyloid Beta Assembly Protein Interactions Lipid Profiles Early Detection Oxidative Stress Caregiving for Alzheimer's SORL1 Gene Mutation Diagnosis Support for Patients Protein Aggregation Obesity and Alzheimer's Cancer Obesity and Alzheimer's Disease Causes of Alzheimer's Tauopathy Research on Alzheimer's Disease Epidemiology Cognitive Decline Episodic Memory Memory Improvement Gut-Brain Axis Therapeutic Strategies Muscle Weakness Oligodendrocytes and Amyloid Beta Production APOE Isoforms Amyloid Plaques Drug Development Insulin Resistance

Nanoparticles Restore Brain Barrier, Reverse Alzheimer’s Signs in Mice

Independent experts say the mouse results must be replicated before testing in people.

Study Ties Obesity to Alzheimer’s Plaque via Fat-Derived Vesicles

Molecular 'Magnifying Glass' Flags Early Protein Aggregation in Living Cells

Alzheimer’s Study Ties Familial SORL1 Variant to Fewer, Weaker Brain Exosomes

Alzheimer’s Study Traces Gut B Cells to the Brain, Pointing to CXCR4 Target in Mice

Study Identifies Midkine as Blocker of Alzheimer’s Amyloid‑β Assembly

Brain Hemoglobin Identified as an Antioxidant Target as Oral Molecule Protects Mice Across Disease Models

Thymosin β4 Reverses Early Alzheimer’s Defects in Organoids and Mouse Models

Global Proteomics Consortium Reveals Immune Signature and Disease-Specific Markers in Brain Disorders

Low-Intensity rTMS Temporarily Restores Synaptic Plasticity in Alzheimer’s Mice

Large-Scale Genomics Study Maps Molecular Triggers of Alzheimer’s Protein Aggregation

Lab-Grown Aged Neurons Reveal Molecular Stress as Driver of Neurodegeneration

STING molecule drives Alzheimer’s damage in mice, offering new therapeutic avenue